Investment Details
Investor Type
Venture Capital
Asset Class Focus
Biotechnology, Life Science, Neuroscience
Stage Focus
Pre-Seed, Seed, Early Stage
Geographical Focus
United States, United Kingdom, Spain, Sweden
Industries Focus
- Healthcare
- Pharmaceuticals
- Biotechnology
- Therapeutics
- Mental Health
Investment Size:
50,000 to 500,000 USD
Investor Details Founded: 2021
Ayuh Ventures is an early-stage venture capital firm investing in startups focused on neuroscience to address longevity and aging. The firm targets companies developing solutions in mental health, psychedelics, aging, and fertility sectors. Ayuh Ventures aims to push the limits of modern science and support founders working on under-researched health issues.
Founded in 2021 and headquartered in Dover, Delaware, United States, Ayuh Ventures has made investments in companies such as Samphire Neuroscience, which specializes in developing neurotechnological solutions for women's health. The firm's investment approach emphasizes backing early-stage startups that are transforming the healthcare and wellness industries.
Ayuh Ventures' investment thesis revolves around supporting companies with scalable business models and innovative technologies that address key challenges in healthcare. By offering both financial backing and strategic guidance, the firm aims to help startups grow, drive innovation in healthcare, and achieve long-term impact and success.
Requirements
- Scalable business models
- Innovative technologies addressing healthcare challenges
- Focus on longevity and aging sectors
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Samphire Neuroscience
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$14.95
-
$39.95
-
$299.00
Claim this Investor
Are you an official representative of Ayuh Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim